Zobrazeno 41 - 50
of 992
pro vyhledávání: '"11"'
Autor:
Ferry Hagen, Felcia Lai, Jos Houbraken, Paul E. Verweij, David E. Hibbs, Paul W. Groundwater, Vanessa R. Barrs, Robert A. Samson, Sarah E. Kidd, Jacques F. Meis, Jens Christian Frisvad, Jessica J. Talbot
Publikováno v:
Antimicrobial Agents and Chemotherapy
Antimicrobial Agents and Chemotherapy, 63
Antimicrobial Agents and Chemotherapy, 63, 11
Talbot, J J, Frisvad, J C, Meis, J F, Hagen, F, Verweij, P E, Hibbs, D E, Lai, F, Samson, R A, Kidd, S E, Barrs, V R & Houbraken, J 2019, ' Cyp51A mutations, Extrolite Profiles and Antifungal Susceptibility in Clinical and Environmental Isolates of the Aspergillus viridinutans Species Complex ', Antimicrobial Agents and Chemotherapy, vol. 63, no. 11, e00632-19 . https://doi.org/10.1128/AAC.00632-19
Antimicrobial Agents and Chemotherapy, 63(11). American Society for Microbiology
Antimicrobial Agents and Chemotherapy, 63
Antimicrobial Agents and Chemotherapy, 63, 11
Talbot, J J, Frisvad, J C, Meis, J F, Hagen, F, Verweij, P E, Hibbs, D E, Lai, F, Samson, R A, Kidd, S E, Barrs, V R & Houbraken, J 2019, ' Cyp51A mutations, Extrolite Profiles and Antifungal Susceptibility in Clinical and Environmental Isolates of the Aspergillus viridinutans Species Complex ', Antimicrobial Agents and Chemotherapy, vol. 63, no. 11, e00632-19 . https://doi.org/10.1128/AAC.00632-19
Antimicrobial Agents and Chemotherapy, 63(11). American Society for Microbiology
The past decade has seen an increase in aspergillosis in humans and animals due to Aspergillus viridinutans species complex members. Azole resistance is common to these infections, carrying a poor prognosis. cyp51A gene mutations are the main cause o
Autor:
Hamidou Traore, Hector Rodriguez-Villalobos, Paul M. Tulkens, Françoise Van Bambeke, Olivier Denis, Francis Vanderbist, Ariane Deplano, Anne Vergison, J. Stuart Elborn, Hussein Chalhoub, Muhammad Hariri Mustafa, Michael M. Tunney, Barbara C. Kahl
Publikováno v:
Mustafa, M-H, Chalhoub, H, Denis, O, Deplano, A, Vergison, A, Rodriguez-Villalobos, H, Elborn, J S, Tunney, M M, Kahl, B C, Traore, H, Vanderbist, F, Tulkens, P M & Van Bambeke, F 2016, ' Antimicrobial susceptibility of Pseudomonas aeruginosa isolated from cystic fibrosis patients through Northern Europe ', Antimicrobial Agents and Chemotherapy, vol. 60, no. 11, pp. 6735-6741 . https://doi.org/10.1128/AAC.01046-16
Antimicrobial Agents and Chemotherapy, Vol. 60, no. 11, p. 6735-6741 (2016)
Antimicrobial Agents and Chemotherapy, Vol. 60, no. 11, p. 6735-6741 (2016)
Pseudomonas aeruginosa is a major cause of morbidity and mortality in cystic fibrosis patients. This study compared the antimicrobial susceptibilities of 153 P. aeruginosa isolates from the United Kingdom (UK) ( n = 58), Belgium ( n = 44), and German
Autor:
Laura McEntee, William W. Hope, Aaron Dane, Akash Jain, Jennifer Unsworth, Ian A. Critchley, Nicola Farrington, Shampa Das, Nicole Cotroneo, David Melnick, Adam Johnson, Thomas R. Parr, Paul G. Ambrose
Publikováno v:
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Tebipenem pivoxil HBr (TBPM-PI-HBr) is a novel orally bioavailable carbapenem. The active moiety is tebipenem. Tebipenem pivoxil is licensed for use in Japan in children with ear, nose, and throat infections and respiratory infections. The HBr salt w
Autor:
Marguerite L. Monogue, Masakatsu Tsuji, Roger Echols, Sean M. Stainton, David P. Nicolau, Yoshinori Yamano
Publikováno v:
Antimicrobial Agents and Chemotherapy
Herein, we evaluated sustainability of humanized exposures of cefiderocol in vivo over 72 h against pathogens with cefiderocol MICs of 0.5 to 16 μg/ml in the neutropenic murine thigh model. In Acinetobacter baumannii, Pseudomonas aeruginosa, and Ent
Autor:
Paola Vacca, Arianna Neri, Cecilia Fazio, Annapina Palmieri, Paola Stefanelli, Luigina Ambrosio
Publikováno v:
Antimicrobial Agents and Chemotherapy. 62
The aim of this study was to evaluate the antimicrobial susceptibilities of 866 Neisseria meningitidis invasive strains during 11 years of surveillance in Italy. Two and six strains were resistant to ciprofloxacin and rifampin, respectively. Forty-fi
Autor:
Christelle M. Roux, Carlos Leon, Briana M. Young, Renée M. Tsolis, Vidya L. Atluri, Maria G. Winter, Lisa Tran, Tobias Kerrinnes
Publikováno v:
Antimicrobial agents and chemotherapy, vol 59, iss 11
Kerrinnes, T; Young, BM; Leon, C; Roux, CM; Tran, L; Atluri, VL; et al.(2015). Phospholipase A1 modulates the cell envelope phospholipid content of brucella melitensis, contributing to polymyxin resistance and pathogenicity. Antimicrobial Agents and Chemotherapy, 59(11), 6717-6724. doi: 10.1128/AAC.00792-15. UC Davis: Retrieved from: http://www.escholarship.org/uc/item/0w34d8s5
Kerrinnes, T; Young, BM; Leon, C; Roux, CM; Tran, L; Atluri, VL; et al.(2015). Phospholipase A1 modulates the cell envelope phospholipid content of brucella melitensis, contributing to polymyxin resistance and pathogenicity. Antimicrobial Agents and Chemotherapy, 59(11), 6717-6724. doi: 10.1128/AAC.00792-15. UC Davis: Retrieved from: http://www.escholarship.org/uc/item/0w34d8s5
A subset of bacterial pathogens, including the zoonotic Brucella species, are highly resistant against polymyxin antibiotics. Bacterial polymyxin resistance has been attributed primarily to the modification of lipopolysaccharide; however, it is unkno
Autor:
Rémy A. Bonnin, Pierre Bogaerts, Daniel T. Huang, Thierry Naas, Agustin Zavala, Youri Glupczynski, Laura Dabos, Bogdan I. Iorga, Pierre Sacré
Publikováno v:
Antimicrobial Agents and Chemotherapy, Vol. 62, no. 8, p. :e00469-18 [1-6] (2018)
Antimicrobial Agents and Chemotherapy
Antimicrobial Agents and Chemotherapy, American Society for Microbiology, 2018, 62 (8), pp.e00469-18. ⟨10.1128/AAC.00469-18⟩
Antimicrobial Agents and Chemotherapy
Antimicrobial Agents and Chemotherapy, American Society for Microbiology, 2018, 62 (8), pp.e00469-18. ⟨10.1128/AAC.00469-18⟩
A multidrug-resistant Klebsiella pneumoniae 1210 isolate with reduced carbapenem susceptibility revealed the presence of a novel plasmid-encoded blaOXA-48-like gene, named blaOXA-519 The 60.7-kb plasmid (pOXA-519) was similar to the IncL-OXA-48 proto
Autor:
S. Lalanne, Camille Tron, Florian Lemaitre, Eric Bellissant, Marie-Clémence Verdier, Antoine Petitcollin, S. Nimubona, C. Boglione-Kerrien
Publikováno v:
Antimicrobial Agents and Chemotherapy
Antimicrobial Agents and Chemotherapy, American Society for Microbiology, 2017, 61 (11), pp.e01166-17. ⟨10.1128/AAC.01166-17⟩
Antimicrobial Agents and Chemotherapy, 2017, 61 (11), pp.e01166-17. ⟨10.1128/AAC.01166-17⟩
Antimicrobial Agents and Chemotherapy, American Society for Microbiology, 2017, 61 (11), pp.e01166-17. ⟨10.1128/AAC.01166-17⟩
Antimicrobial Agents and Chemotherapy, 2017, 61 (11), pp.e01166-17. ⟨10.1128/AAC.01166-17⟩
Posaconazole is extensively used for prophylaxis for invasive fungal infections. The gastro-resistant tablet formulation has allowed the bioavailability issues encountered with the oral suspension to be overcome. However, overexposure is now frequent
Autor:
Valérie Nicolas, Loïc Martin, Kawthar Bouchemal, Roger Le Grand, Davide Gibellini, David Lembo, Armand Koffi, Nathalie Dereuddre-Bosquet, Armelle Aka-Any-Grah, Vanessa Lievin-Le-Moal, Gilles Ponchel, Christian Poüs
Publikováno v:
Antimicrobial Agents and Chemotherapy
Antimicrobial Agents and Chemotherapy, American Society for Microbiology, 2015, 59 (4), pp.2215-2222. ⟨10.1128/AAC.03503-14⟩
Antimicrobial Agents and Chemotherapy, 2015, 59 (4), pp.2215-2222. ⟨10.1128/AAC.03503-14⟩
Antimicrobial Agents and Chemotherapy, American Society for Microbiology, 2015, 59 (4), pp.2215-2222. ⟨10.1128/AAC.03503-14⟩
Antimicrobial Agents and Chemotherapy, 2015, 59 (4), pp.2215-2222. ⟨10.1128/AAC.03503-14⟩
To be efficient, vaginal microbicide hydrogels should form a barrier against viral infections and prevent virus spreading through mucus. Multiple particle tracking was used to quantify the mobility of 170-nm fluorescently labeled COOH-modified polyst
Publikováno v:
Antimicrobial Agents and Chemotherapy. 58:7198-7204
Tedizolid, the active moiety of tedizolid phosphate, is a recently approved oxazolidinone antibacterial with activity against a wide range of Gram-positive pathogens, including resistant strains such as methicillin-resistant Staphylococcus aureus . T